During the past decade, Centre Hospitalier General conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier General" #1 sponsor was "UNICANCER" with 5 trials, followed by "University Hospital, Limoges" with 5 trials sponsored, "Federation Francophone de Cancerologie Digestive" with 2 trials sponsored, "The Lymphoma Academic Research Organisation" with 2 trials sponsored and "CeloNova BioSciences, Inc." with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier General" #1 collaborator was "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials as a collaborator, "Federation Francophone de Cancerologie Digestive" with 2 trials as a collaborator, "AlpinARC" with 1 trials as a collaborator, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 1 trials as a collaborator and "Grupo Espanol Tratamiento Tumores Digestivos" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier General" are "Breast Cancer" (5 trials), "Colorectal Cancer" (4 trials), "Diffuse Large B-cell Lymphoma" (2 trials), "ACS - Acute Coronary Syndrome" (1 trials) and "Abdominal Aortic Aneurysm" (1 trials). Many other conditions were trialed in "Centre Hospitalier General" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier General" are "Drug" (15 trials), "Procedure" (6 trials), "Biological" (3 trials), "Other" (3 trials) and "Genetic" (2 trials). Other intervention types were less common.

The name of intervention was led by "fluorouracil" (7 trials), "adjuvant therapy" (3 trials), "cyclophosphamide" (3 trials), "epirubicin hydrochloride" (3 trials) and "leucovorin calcium" (3 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier General" are 18 trials for "All" genders and 9 trials for "Female" genders.

Currently, there are NaN active trials in "Centre Hospitalier General". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Centre Hospitalier General, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier General, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".

Centre Hospitalier General has several departments that took part in Clinical trials: "Ch De Brive La Gaillarde; Radiotherapie Oncologie" - 6 trials